Abiopharma

🔍 Backus Robert (Executive)

Company: Albertsons Companies, Inc. (ACI)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 130 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 12,363.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 140 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,320.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 260 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,805.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 741 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,566.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2
• Acquired 502 shares of Dividend Equivalent Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 47,845.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: Performance Based Restricted stock units ("PBRSUs") credited to the reporting person's account as dividend equivalents on unvested PBRSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.17 per share of common stock.
• F2: Restricted stock units ("RSUs") credited to the reporting person's account as dividend equivalents on unvested RSUs and will vest and settle with the underlying awards. The reported number is the quarterly dividend equivalent to $0.17 per share of common stock.